Expert Opinion on Therapeutic Targets : Impact Factor & More
eISSN: 1744-7631pISSN: 1472-8222
Share this on:
Aims and Scope of Expert Opinion on Therapeutic Targets
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001. Less
Key Metrics
CiteScore 
9.8
Eigenfactor
0.005 - 0.01
H-Index
101
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.33
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Expert Opinion on Therapeutic Targets
Expert Opinion on Therapeutic Targets Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Therapeutic Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on Expert Opinion on Therapeutic Targets
How long has Expert Opinion on Therapeutic Targets been actively publishing? 
What is the publishing frequency of Expert Opinion on Therapeutic Targets?
What is the eISSN & pISSN for Expert Opinion on Therapeutic Targets?
What is Citescore for Expert Opinion on Therapeutic Targets?
What is the H Index for Expert Opinion on Therapeutic Targets ?
What is SNIP score for Expert Opinion on Therapeutic Targets?
What is the SJR for Expert Opinion on Therapeutic Targets?
Who is the publisher of Expert Opinion on Therapeutic Targets?
